Prevention of Ventricular Fibrillation by Cilostazol, an Oral Phosphodiesterase Inhibitor, in a Patient with Brugada Syndrome
- 1 July 2002
- journal article
- case report
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 13 (7) , 698-701
- https://doi.org/10.1046/j.1540-8167.2002.00698.x
Abstract
Cilostazol and Brugada Syndrome. We report the case of 67‐year‐old man with Brugada syndrome, in whom daily episodes of ventricular fibrillation (VF) occurred every early morning for 4 days. The epi...Keywords
This publication has 0 references indexed in Scilit: